
| ½Ã°£ | ÇÁ·Î±×·¥ | ¿¬ÀÚ |
|---|---|---|
| 09:20-09:30 | °³È¸»ç | ¹Î¾ç±â(ÇѸ²ÀÇ´ë, ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ȸÀå) |
| ¥°. Symptom-Based Diagnostic Approach to Neuromuscular Disorders | ÁÂÀå. ¹èÁ¾¼®(ÇѸ²ÀÇ´ë), ±Ç¿ÀÇö(À»ÁöÀÇ´ë) | |
| 09:30-09:55 | Hand weakness | Á¤ÇýÀ±(¿¬¼¼ÀÇ´ë, ½Å°æ°ú) |
| 09:55-10:20 | Foot drop | ÀÌÇü¼ö(±¹¸³Áß¾ÓÀÇ·á¿ø, ½Å°æ°ú) |
| 10:20-10:40 | Winged scapulae | À¯ÇöÁö(°¡Å縯ÀÇ´ë, ½Å°æ°ú) |
| 10:40-10:50 | Q & A | |
| 10:50-11:00 | Intermission | |
| ¥±. Diagnosis and Treatment of Lumbosacral Radiculopathy | ÁÂÀå. ±èº´Á¶(°í·ÁÀÇ´ë), Á¶Áß¾ç(ÀÎÁ¦ÀÇ´ë) | |
| 11:00-11:25 | Practical Diagnostic approach | ¹ÚÇüÁØ(¿¬¼¼ÀÇ´ë, ½Å°æ°ú) |
| 11:25-11:50 | Surgical Strategies | ÃÖÀÏ(ÇѸ²ÀÇ´ë, ½Å°æ¿Ü°ú) |
| 11:50-12:10 | Interventional Procedures : When and How | Á¶ÀçÀÎ(¿¬¼¼ÀÇ´ë, ¸¶ÃëÅëÁõÀÇÇаú) |
| 12:10-12:20 | Q & A | |
| 12:20-13:00 | ÃÑȸ ¹× Á¡½É½Ã°£ | ¾È¼ÒÇö(ÇѸ²ÀÇ´ë, ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ Ãѹ«ÀÌ»ç) |
| ¥². Interpreting My Tests: Practical Clinical Insights | ÁÂÀå. È«À±È£(¼¿ïÀÇ´ë), ½Å°æÁø(ÀÎÁ¦ÀÇ´ë) | |
| 13:00-13:20 | Electrodiagnostic studies Made Practical | ±èÁöÀº(¼øÃµÇâÀÇ´ë, ½Å°æ°ú) |
| 13:20-13:40 | Autoantibody Testing in Practice : A Rheumatologist¡¯s Perspective for Neurologists | Á¶¼ö°æ(ÇѾçÀÇ´ë, ·ù¸¶Æ¼½º³»°ú) |
| 13:40-14:00 | NGS in Practice from Variants to Diagnosis | ±èÁø¾Æ(¼¿ïÀÇ´ë, ½Å°æ°ú) |
| 14:00-14:10 | Q & A | |
| 14:10-14:20 | Intermission | |
| ¥³. Exercise Strategies in Patients with Neuromuscular Disorders | ÁÂÀå. ¹Î¾ç±â(ÇѸ²ÀÇ´ë), ÀÓ¿µ¹Î(¿ï»êÀÇ´ë) | |
| 14:20-14:40 | Exercise as Therapy : Mechanism in Neuromuscular disorders | À±º°¾Æ(µ¿¾ÆÀÇ´ë, ½Å°æ°ú) |
| 14:40-15:00 | Rehabilitation in Practice | ±è¼ö¿¬(ºÎ»êÀÇ´ë, ÀçȰÀÇÇаú) |
| 15:00-15:20 | Dysphagia : Evaluation and Rehabilitation | ¹ÚÁø¿µ(¿¬¼¼ÀÇ´ë, ÀçȰÀÇÇаú) |
| 15:20-15:30 | Q & A | |
| 15:30-15:40 | Intermission | |
| ¥´. Emerging Therapies in Neuromuscular Disorders | ÁÂÀå. ¼¹üõ(¼º±Õ°üÀÇ´ë), ±è»ó¹ü(°æÈñÀÇ´ë) | |
| 15:40-16:00 | Myasthenia Gravis : New Therapeutic Horizons | ºÀÁ¤ºó(Á¶¼±ÀÇ´ë, ½Å°æ°ú) |
| 16:00-16:20 | Immune-Mediated Neuropathy : Advances in Treatment | ¹Î¿µ±â(¿¬¼¼ÀÇ´ë, ½Å°æ°ú) |
| 16:20-16:40 | Gene-modulating therapies : The Future of Neuromuscular disorders | ¿À±â¿í(ÇѾçÀÇ´ë, ½Å°æ°ú) |
| 16:40-16:50 | Q & A | |
| 16:50- | ÄûÁî Ãß÷ ¹× Æóȸ»ç | |





